← SynDRA
LASOFOXIFENE
SynDRA canonical compound SYN0003877 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ESR1 | ESR2 |
|---|
| Mechanism of action | selective estrogen receptor modulator (SERM) |
|---|
| Indication | breast cancer | osteoporosis |
|---|
| Disease area | oncology | orthopedics |
|---|
All known targets
- ESR1
- ESR2
- Esr1
- Esr2
- RSV F
Mechanisms of action (all sources)
- ESR2 MODULATOR
- ESR1 MODULATOR
- ESR1 PARTIAL AGONIST
- ESR2 PARTIAL AGONIST
- selective estrogen receptor modulator (SERM)
- RSV F MODULATOR
- ESR1 AGONIST
- ESR2 AGONIST
ATC classes
- G03X · OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Cross-references
Synonyms
- Lasofoxifeno
- Oporia
- rac-Lasofoxifene
- CP 336156
- Fablyn
- UNII-337G83N988
- (5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol
- CHEMBL328190
- 337G83N988
- (-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol
- CP-336,156
- LASOFOXIFENE HCL
- Lasofoxifene [INN:BAN]
- AC1L50OI
- SCHEMBL26815
- GTPL7542
- CTK8F1062
- BDBM20606
- DTXSID50171037
- GXESHMAMLJKROZ-IAPPQJPRSA-N
- ZINC3918428
- BCP03626
- AKOS030241621
- AN-3516
- BCP9000842
- DB06202
- Lasofoxifene [INN]
- Cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene, tartrate salt
- AZD9639
- lasofoxifeno
- CP-336156
- lasofoxifenum
- CHEBI:135938
- RefChem:924541
- DTXCID8093528
- G03XC03
- C3D
- LASOFOXIFENE [MI]
- LASOFOXIFENE [MART.]
Look up LASOFOXIFENE in the interactive SynDRA portal →